IGFBP2 and central nervous system cancer: Several serum biomarkers-YKL40, MMP9, B-chain of α2-Heremans-Schmid glycoprotein (AHSG), Haptaglobin α2, Osteopontin and IGFBP2 have been reported to identify glioma [19,20,37,38,39,40].